Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.

Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.

Ageno W, Spyropoulos AC, Turpie AG.

Thromb Haemost. 2012 Jun;107(6):1027-34. doi: 10.1160/TH11-11-0787. Epub 2012 Mar 22. Review.

PMID:
22437976
2.

Rivaroxaban: an oral factor Xa inhibitor.

Thomas TF, Ganetsky V, Spinler SA.

Clin Ther. 2013 Jan;35(1):4-27. doi: 10.1016/j.clinthera.2012.12.005. Review.

PMID:
23328267
3.

Unanswered questions in venous thromboembolism.

Weitz JI.

Thromb Res. 2009;123 Suppl 4:S2-S10. doi: 10.1016/S0049-3848(09)70135-5. Review.

PMID:
19303498
4.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
5.

Thromboprophylaxis in surgical and medical patients.

Bozzato S, Galli L, Ageno W.

Semin Respir Crit Care Med. 2012 Apr;33(2):163-75. doi: 10.1055/s-0032-1311795. Epub 2012 May 30. Review.

PMID:
22648489
6.

The use of rivaroxaban for short- and long-term treatment of venous thromboembolism.

Cohen AT, Dobromirski M.

Thromb Haemost. 2012 Jun;107(6):1035-43. doi: 10.1160/TH11-12-0859. Epub 2012 Feb 28. Review.

PMID:
22371186
7.

Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.

Merli G, Spyropoulos AC, Caprini JA.

Ann Surg. 2009 Aug;250(2):219-28. doi: 10.1097/SLA.0b013e3181ae6dbe. Review.

PMID:
19638915
8.

Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.

Becattini C, Vedovati MC, Agnelli G.

Thromb Res. 2012 Mar;129(3):392-400. doi: 10.1016/j.thromres.2011.12.014. Epub 2012 Jan 20. Review.

PMID:
22264937
9.

Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.

Imberti D, Gallerani M, Manfredini R.

J Thromb Thrombolysis. 2012 Aug;34(2):208-13. doi: 10.1007/s11239-012-0716-8.

PMID:
22466929
10.

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

Eriksson BI, Friedman RJ.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:25S-31S. doi: 10.1177/1076029609340668. Epub 2009 Jul 31. Review.

PMID:
19648146
11.

Dabigatran etexilate: future directions in anticoagulant treatment.

Schulman S, Reilly PA.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:32S-41S. doi: 10.1177/1076029609344199. Epub 2009 Aug 13. Review.

PMID:
19679590
12.

Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.

Yoshida Rde A, Yoshida WB, Maffei FH, El Dib R, Nunes R, Rollo HA.

Ann Vasc Surg. 2013 Apr;27(3):355-69. doi: 10.1016/j.avsg.2012.06.010. Epub 2013 Jan 23. Review.

PMID:
23351997
13.

Asian venous thromboembolism guidelines: prevention of venous thromboembolism.

Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, Ho CO, Ibrahim H, Kim TK, Kritpracha B, Lee LH, Lee L, Lee WY, Li YJ, Nicolaides AN, Oh D, Pratama D, Ramakrishnan N, Robless PA, Villarama-Alemany G, Wong R; Asian Venous Thrombosis Forum.

Int Angiol. 2012 Dec;31(6):501-16. Review.

PMID:
23222928
14.

The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.

Dobesh P.

Int J Clin Pract. 2010 Oct;64(11):1554-62. doi: 10.1111/j.1742-1241.2010.02447.x. Review.

PMID:
20846203
15.

Improving prevention and treatment of venous thromboembolism: clinical trial results.

Mahan C, Spyropoulos AC.

J Med Econ. 2012;15(4):611-22. doi: 10.3111/13696998.2012.667026. Epub 2012 Feb 28. Review.

PMID:
22372589
16.

Implications of new anticoagulants in primary practice.

Perez A, Eraso LH, Merli GJ.

Int J Clin Pract. 2013 Feb;67(2):139-56. doi: 10.1111/ijcp.12023. Review. Erratum in: Int J Clin Pract. 2013 Aug;67(8):816. Dosage error in article text.

PMID:
23305476
17.

Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we under-treating our patients?

Roth-Yelinek B.

Eur J Intern Med. 2012 Apr;23(3):236-9. doi: 10.1016/j.ejim.2011.11.005. Epub 2011 Dec 6.

PMID:
22385880
18.

Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.

Dahl OE.

Clin Appl Thromb Hemost. 2009 Sep-Oct;15 Suppl 1:17S-24S. doi: 10.1177/1076029609344588. Epub 2009 Aug 19. Review.

PMID:
19696041
19.

New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients.

Galanis T, Merli GJ.

J Thromb Thrombolysis. 2013 Aug;36(2):141-8. doi: 10.1007/s11239-013-0955-3. Review.

PMID:
23846736
20.

New anticoagulants: focus on venous thromboembolism.

Gómez-Outes A, Lecumberri R, Pozo C, Rocha E.

Curr Vasc Pharmacol. 2009 Jul;7(3):309-29. Review.

PMID:
19601856

Supplemental Content

Support Center